Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) Invested Capital: 2009-2025

Historic Invested Capital for Rockwell Medical (RMTI) over the last 15 years, with Sep 2025 value amounting to $37.9 million.

  • Rockwell Medical's Invested Capital rose 23.04% to $37.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.9 million, marking a year-over-year increase of 23.04%. This contributed to the annual value of $34.1 million for FY2024, which is 45.93% up from last year.
  • Latest data reveals that Rockwell Medical reported Invested Capital of $37.9 million as of Q3 2025, which was up 19.78% from $31.6 million recorded in Q2 2025.
  • Over the past 5 years, Rockwell Medical's Invested Capital peaked at $37.9 million during Q3 2025, and registered a low of -$1.8 million during Q1 2022.
  • Over the past 3 years, Rockwell Medical's median Invested Capital value was $25.3 million (recorded in 2024), while the average stood at $26.3 million.
  • Its Invested Capital has fluctuated over the past 5 years, first tumbled by 106.66% in 2022, then surged by 919.19% in 2023.
  • Over the past 5 years, Rockwell Medical's Invested Capital (Quarterly) stood at $23.1 million in 2021, then rose by 0.74% to $23.3 million in 2022, then rose by 0.31% to $23.4 million in 2023, then surged by 45.93% to $34.1 million in 2024, then rose by 23.04% to $37.9 million in 2025.
  • Its Invested Capital stands at $37.9 million for Q3 2025, versus $31.6 million for Q2 2025 and $32.9 million for Q1 2025.